Envestnet Asset Management
ABVX

Envestnet Asset Management’s Abivax ABVX Stock Holding History

Envestnet Asset Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.44M Buy
63,354
+4,145
+7% +$469K ﹤0.01% 2054
2026
Q1 		$6.59M Buy
59,209
+13,541
+30% +$1.6M ﹤0.01% 2122
2025
Q4 		$6.16M Buy
45,668
+25,368
+125% +$2.77M ﹤0.01% 2034
2025
Q3 		$1.72M Buy
+20,300
New +$1.24M ﹤0.01% 2978

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management's ABVX Position: Q2 2026 in Review

Envestnet Asset Management increased its Abivax (ABVX) stake by 7% in Q2 2026, buying an estimated $469K and bringing the position to 63,354 shares worth $8.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2054.

Envestnet Asset Management first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Envestnet Asset Management held 63,354 shares of Abivax worth $8.44M as of Q2 2026.
  • Envestnet Asset Management bought 4,145 Abivax shares in Q2 2026, an estimated $469K.
  • Abivax made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2054 holding.
  • Envestnet Asset Management first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.